TGR Biosciences Announces License Agreement With Abcam plc

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ADELAIDE, Australia--(BUSINESS WIRE)--TGR BioSciences Pty Ltd (TGR), a leading developer of advanced cell-based assay technologies, is pleased to announce a license agreement with Abcam plc, of Cambridge, UK, a producer and distributor of high quality protein research tools. Under the agreement Abcam will develop and manufacture immunoassay products that incorporate TGR’s proprietary CaptSure™ assay technology. Immunoassays incorporating CaptSure are highly sensitive, offer considerable time savings, and are easy to perform when compared with conventional sandwich immunoassays.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC